- Sorted by date
- Hybrid Sort
- Smart Random Sort
- Sort by relevance
Advertisements
» Related Searches: laser treatment, Treatment, lung cancer treatment, laser treatment smoking, breast cancer treatment
Results 51 to 60 of 533 
Volume 43, number S4: Buprenorphine and HIV Primary Care: New …
… treatment of disease—for example, treatment of acquired immunodeficiency
syndrome (AIDS) with highly active antiretroviral therapy. In an effort to improve the
opportunity for treatment of drug abuse and HIV infection … 
Volume 43, number S4: Opioid Dependence: Rationale for and Efficacy …
… treatment of opioid dependence and can contribute to a decreased risk of human
immunodeficiency virus (HIV) transmission. In addition, a buprenorphine/naloxone
combination appears to have a decreased potential for abuse …
Volume 43, number S4: The Potential Role of Buprenorphine in …
Untreated opioid dependence is a major obstacle to the successful treatment and
prevention of human immunodeficiency virus (HIV) infection. In this review, we examine the
interwoven epidemics of HIV infection …
Volume 43, number S4: A Trial of Integrated Buprenorphine/Naloxone and …
… treatment of opioid dependence in HIV specialty settings. We investigated the
feasibility and efficacy of integrating buprenorphine, along with 2 levels of counseling,
into HIV clinical care. Methods. HIV-positive, opioid-dependent …
Volume 43, number S4: Initial Strategies for Integrating Buprenorphine into …
… treatment who are successfully linked to services for these 2 conditions. There
is evidence that integrating care for HIV infection and substance abuse optimizes outcomes
for patients with both disorders …
Volume 43, number S4: Buprenorphine Use: The International Experience
… treatment models (in the United States, Australia, Germany, and Italy) and
buprenorphine use in specific populations are also reviewed in the present article. In
countries experiencing a dual epidemic of …
MedCath Corp Reports Q4 and FYE 2006 Results
MedCath Corp, a healthcare provider focused primarily on the diagnosis and treatment
of cardiovascular disease, announced operating results for its Q4 and FYE 9/30/2006 …
A whole new battle
… treatment." That was the case for one New Jersey family when their …
AtheroGenics and AstraZeneca Win Best Partnership Alliance of the Year …
AtheroGenics, Inc. (NASDAQ: AGIX), a pharmaceutical company focused on the treatment
of chronic inflammatory diseases, today announced winning the "Best Partnership Alliance
of the Year" award …
Minister's visits Justice Iyer
… treatment in a private hospital, here …